Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment for Dupuytren’s contracture. In ...

Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...

Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is effective in reducing nodule hardness and nodule size. Researchers at the Kennedy Institute, University of Oxford, led by ...

A drug already on the market for 20 years effectively reduced nodules associated with Dupuytren's disease in a mid-stage trial, researchers said. Patients receiving intranodular injections of ...

In a large, head-to-head trial pitting collagenase injections against limited fasciotomy as treatments for Dupuytren's contracture, the knife won. In the open-label trial, self-reported hand health ...

Treatment options for Dupuytren’s contracture include limited fasciectomy and collagenase injection, but data comparing the two approaches are lacking. New research findings are summarized in a short ...

Dupuytrens Contracture is a condition in which a person's fingers bend toward the palm and cannot be fully extended. The condition can make working, and even daily functioning, difficult. Dr. Tom ...

Dupuytren's contracture is a condition that causes the layer of fibrous connective tissue just under the skin to shorten over time, often pulling the finger joints toward the palm. When this ...

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early-stage Dupuytren's ...

Clinical trial seems to show Dupuytren’s disease reversed by rheumatoid arthritis drug Researchers have hailed a breakthrough in the treatment of a common, incurable disease that causes hand ...

What is Dupuytren’s disease? Why does it develop in some people and how strong is the hereditary component? Dupuytren’s disease is a progressive fibro-proliferative disorder in which normal fascial ...